The global market for NK cell therapeutics is still in its infancy. There isn't any NK cell therapy available right now. Many biopharmaceutical companies are working to investigate and develop novel immunotherapies, including NK cell treatments, which have the potential to be the next-generation treatment for acute infectious diseases and cancer.For instance, major players such as Affimed N.V.,...